List of Tables
Table 1. Radiopharmaceuticals in Nuclear Medical Market Trends
Table 2. Radiopharmaceuticals in Nuclear Medical Market Drivers & Opportunity
Table 3. Radiopharmaceuticals in Nuclear Medical Market Challenges
Table 4. Radiopharmaceuticals in Nuclear Medical Market Restraints
Table 5. Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
Table 7. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Radiopharmaceuticals in Nuclear Medical Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Radiopharmaceuticals in Nuclear Medical
Table 13. Global Radiopharmaceuticals in Nuclear Medical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medical as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2019-2024) & (USD/MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2025-2030) & (USD/MT)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2019-2024) & (USD/MT)
Table 39. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2025-2030) & (USD/MT)
Table 40. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2019-2024) & (%)
Table 44. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Region (2025-2030) & (%)
Table 45. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2019-2024) & (%)
Table 49. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Region (2025-2030) & (%)
Table 50. Global Radiopharmaceuticals in Nuclear Medical Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Radiopharmaceuticals in Nuclear Medical Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume, (2025-2030) & (K MT)
Table 57. Bracco Imaging Company Information
Table 58. Bracco Imaging Introduction and Business Overview
Table 59. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 61. Bracco Imaging Recent Development
Table 62. Cambridge Isotope Laboratories Company Information
Table 63. Cambridge Isotope Laboratories Introduction and Business Overview
Table 64. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 66. Cambridge Isotope Laboratories Recent Development
Table 67. Cardinal Health Company Information
Table 68. Cardinal Health Introduction and Business Overview
Table 69. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 71. Cardinal Health Recent Development
Table 72. Medtronic Company Information
Table 73. Medtronic Introduction and Business Overview
Table 74. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Medtronic Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 76. Medtronic Recent Development
Table 77. Eczacibasi-Monrol Company Information
Table 78. Eczacibasi-Monrol Introduction and Business Overview
Table 79. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 81. Eczacibasi-Monrol Recent Development
Table 82. Fujifilm Holdings Corporation Company Information
Table 83. Fujifilm Holdings Corporation Introduction and Business Overview
Table 84. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 86. Fujifilm Holdings Corporation Recent Development
Table 87. GE Healthcare (Subsidiary Of General Electric Company) Company Information
Table 88. GE Healthcare (Subsidiary Of General Electric Company) Introduction and Business Overview
Table 89. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 91. GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table 92. IBA Group Company Information
Table 93. IBA Group Introduction and Business Overview
Table 94. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. IBA Group Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 96. IBA Group Recent Development
Table 97. Lantheus Medical Imaging Company Information
Table 98. Lantheus Medical Imaging Introduction and Business Overview
Table 99. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 101. Lantheus Medical Imaging Recent Development
Table 102. Nordion Company Information
Table 103. Nordion Introduction and Business Overview
Table 104. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Nordion Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 106. Nordion Recent Development
Table 107. Ntp Radioisotopes Company Information
Table 108. Ntp Radioisotopes Introduction and Business Overview
Table 109. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 111. Ntp Radioisotopes Recent Development
Table 112. Siemens Healthcare Company Information
Table 113. Siemens Healthcare Introduction and Business Overview
Table 114. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 116. Siemens Healthcare Recent Development
Table 117. Taiyo Nippon Sanso Corporation Company Information
Table 118. Taiyo Nippon Sanso Corporation Introduction and Business Overview
Table 119. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 120. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 121. Taiyo Nippon Sanso Corporation Recent Development
Table 122. Urenco Limited Company Information
Table 123. Urenco Limited Introduction and Business Overview
Table 124. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 125. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 126. Urenco Limited Recent Development
Table 127. Rotem Industries Company Information
Table 128. Rotem Industries Introduction and Business Overview
Table 129. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 130. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Offerings
Table 131. Rotem Industries Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Radiopharmaceuticals in Nuclear Medical Downstream Customers
Table 135. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medical Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Radiopharmaceuticals in Nuclear Medical Sales Volume (2019-2030) & (K MT)
Figure 5. Global Radiopharmaceuticals in Nuclear Medical Sales Price (2019-2030) & (USD/MT)
Figure 6. Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure 7. Global Radiopharmaceuticals in Nuclear Medical Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Radiopharmaceuticals in Nuclear Medical Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceuticals in Nuclear Medical Revenue in 2023
Figure 10. Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Diagnostic Radiopharmaceuticals Picture
Figure 12. Therapy Radiopharmaceuticals Picture
Figure 13. Enriched Stable Isotopes Picture
Figure 14. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Radiopharmaceuticals in Nuclear Medical Price by Type (2019-2030) & (USD/MT)
Figure 19. Product Picture of Diagnostic Application
Figure 20. Product Picture of Therapeutic Application
Figure 21. Product Picture of Research
Figure 22. Product Picture of Pharmaceutical
Figure 23. Product Picture of Industrial
Figure 24. Global Radiopharmaceuticals in Nuclear Medical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Radiopharmaceuticals in Nuclear Medical Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Radiopharmaceuticals in Nuclear Medical Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 27. Global Radiopharmaceuticals in Nuclear Medical Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Radiopharmaceuticals in Nuclear Medical Price by Application (2019-2030) & (USD/MT)
Figure 29. North America Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Radiopharmaceuticals in Nuclear Medical Sales Volume (%), (2019-2030)
Figure 41. United States Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 47. China Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 49. China Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 59. India Radiopharmaceuticals in Nuclear Medical Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Radiopharmaceuticals in Nuclear Medical Sales Value by Type (%), 2023 VS 2030
Figure 61. India Radiopharmaceuticals in Nuclear Medical Sales Value by Application (%), 2023 VS 2030
Figure 62. Radiopharmaceuticals in Nuclear Medical Industrial Chain
Figure 63. Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
